254 related articles for article (PubMed ID: 37863123)
21.
Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
[TBL] [Abstract][Full Text] [Related]
22. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
23. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.
Zheng D; Ning J; Deng H; Ruan Y; Cheng F
J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612
[TBL] [Abstract][Full Text] [Related]
24. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
25. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
28. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway.
Song X; Ma J
Tissue Cell; 2022 Dec; 79():101954. PubMed ID: 36270072
[TBL] [Abstract][Full Text] [Related]
29. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
Li SJ; Sui MH; Sun ZX; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
[TBL] [Abstract][Full Text] [Related]
30. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
Yang M; Yao P; Lang X; Li X; Zhang D
Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
[TBL] [Abstract][Full Text] [Related]
31. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.
Wang M; Sun X; Xin H; Wen Z; Cheng Y
Cancer Med; 2022 Dec; 11(23):4526-4543. PubMed ID: 35593388
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
33. Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway.
Jia Z; Xie Y; Wu H; Wang Z; Li A; Li Z; Yang Z; Zhang Z; Xing Z; Zhang X
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036398
[TBL] [Abstract][Full Text] [Related]
34. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
[TBL] [Abstract][Full Text] [Related]
35. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
[TBL] [Abstract][Full Text] [Related]
36. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
37. FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.
Lv Z; Wang M; Hou H; Tang G; Xu H; Wang X; Li Y; Wang J; Liu M
Int J Biol Sci; 2023; 19(11):3293-3306. PubMed ID: 37496990
[No Abstract] [Full Text] [Related]
38. IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma.
Liu Y; Xing Z; Yuan M; Xu B; Chen L; Zhang D; Zhou Y; Huang H; Zheng X; Zhang J; Jiang J
Pathol Res Pract; 2022 Oct; 238():154069. PubMed ID: 36029680
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
40. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
